Skip to main content
The Australasian Medical Journal logoLink to The Australasian Medical Journal
editorial
. 2015 Oct 31;8(10):315–319. doi: 10.4066/AMJ.2015.2479

Herb-drug interaction: The importance of communicating with primary care physicians

Rajarshi Bhadra 1, Keyvan Ravakhah 2, Raktim K Ghosh 2,
PMCID: PMC4643608  PMID: 26576202

Introduction

Herbal medicines have been perceived as natural, safe, and economically and socio-culturally acceptable remedies to many illnesses. Complementary and alternative medicine (CAM) includes herbal medicine and yoga as well as homeopathy, chiropractic care, and acupuncture. Herbal products are an important component of complementary and alternative medicine.1 In the United States, complementary and alternative medicine is an approximately $9 billion dollar market, approximately three per cent of national ambulatory healthcare expenditures.2 However, due to intrinsic pharmacokinetic and dynamic interactions, variability in herbal product compositions, unsupervised self-administration, and lack of adequate knowledge about the ingredients and their pharmacological properties, there is a serious risk of potentially adverse herb-drug interactions.

Worldwide prevalence of the use of CAM

A cross-sectional study comprising 463 patients suffering from chronic pain and receiving primary care at 12 US academic health centres showed widespread prevalence of CAM.1 Users of CAM may use conventional and complementary medicines simultaneously, and this raises concerns about herb-drug interactions.2 Physicians may be uncertain about the effects of concomitant use of herbs and allopathic medicines. A study of prescription and use of CAM among physicians and patients in a tertiary hospital in India showed that although doctors use herbal medicines more than patients (58 per cent compared to 38 per cent), they seldom enquired about herbal supplement usage among their patients.3 The same study showed that only 15 per cent of the doctors taking herbal supplements were aware of the sources of information about those products. A national survey among university hospitals in Sweden showed a lack of adequate knowledge about herbal supplements and other CAM modalities among registered healthcare providers in surgical care.4

In the United States, herbal medicine and yoga became popular as CAM between 1997 and 2002.5 However, the surge stabilised and the prevalence rates slightly declined from 18.9 per cent in 2002 to 17.9 per cent in 2007 and 2012 as evidenced by population health interview surveys conducted in those respective years.6 A 2007 survey revealed that approximately 33 per cent of US adults who used herbal supplements disclosed it to their physicians.7 Patients largely self-medicated without informing their doctors.7 Figures were even worse (19 per cent) in an Indian setting.3

Physicians’ perspective and knowledge about herbs and other CAM modalities

Physicians are largely divided on the use of herbal medicine and other CAM modalities.8 American physicians are generally sceptical about the use of herbs and supplements.8 A systematic review of CAM studies has shown that both physician and patient attributes are integral for adequate physician-patient communication about the use of herbal products and other CAM modalities.9,10

Despite personal reservations, physicians need to be aware of patients’ CAM usage in order to practice clinical medicine effectively. This has been shown to be particularly true when treating patients belonging to minority groups. One study showed the rate of non-disclosure of herbal medications was higher among racial and ethnic minority groups and among non-citizens. Impairments in language, diverse cultural factors, and economic reasons have limited the access of such subpopulations to conventional medical care.11

Increasing physician awareness about CAM and herbal products

We believe that steps must be taken to improve knowledge, attitudes, and perceptions about herbal medications amongst primary care and general physicians, as well as to improve physician-patient communication. Ways to integrate herbal and alternative medicine into mainstream conventional medicine include more pharmacokinetic research, conducting studies involving pharmacogenomics (the study of how genes can affect an individual's response to drugs) and adverse drug events, offering continuing medical education (CME) credits for alternative medicine courses, and encouraging active collaboration between conventional medical providers and CAM providers.12 Ways to strengthen effective physician-patient communication should include emphasis on communication and interpersonal skills, cultural sensitivity issues, cost effectiveness, understanding the faith and practice of the community, and most importantly, awareness regarding different CAM therapies.

Clinical implications of herb-drug interactions

Herbs can increase or decrease a prescription drug’s expected activity, leading to either unwanted adverse effects or therapeutic failure. Active ingredients in the herbs can alter remarkably the pharmacokinetic and pharmacodynamic properties of a drug. For example, Co-enzyme Q10, a widely used food supplement, interferes with the efflux transporter P-glycoprotein and thus alters the pharmacokinetics of many drugs.13 In contrast to drug-drug interactions, it is difficult to access information about herb-drug interactions. With the exception of some review articles, reliable resources for such information are limited. Table 1 outlines some common herb-drug interactions.

Table 1: Common herbal supplements, their usage (in brackets) and potential interactions with prescription drugs18-25.

Herb Drug Mechanism of interaction Effect
St. John's Wort Hypericum perforatum (depression) Digoxin Induction of P-glycoprotein by St. John's Wort Reduction in serum digoxin level by 18–25 per cent
St. John's Wort Hypericum perforatum (depression) Indinavir Induction of cytochrome P450 (Cyp450) A 57 per cent reduction of Indinavir area-under-the-curve (AUC)
St. John's Wort Hypericum perforatum (depression) Clopidogrel (Plavix) Induction of cytochrome P450 (Cyp450) Decline in platelet aggregation
St. John's Wort Hypericum perforatum (depression) Tacrolimus Induction of cytochrome P450 (Cyp450) Lower blood levels of the drug
Ginkgo biloba Acetaminophen Antiplatelet activity Increased bleeding time up to 15 min
Ginkgo biloba Sodium valproate Unknown Reduced seizure threshold
Co-enzyme Q Warfarin Procoagulant activity INR reduced from 2–3 to 1.31
Ginger (Zingiber officinale) NSAIDS Unknown No symptomatic relief from pain
Ginseng (Ginseng (Panax ginseng) Warfarin Unknown INR declined to 1.5
Kava (Piper methisticum) Promethazine biperiden Dopamine antagonism Involuntary neck extension
Grapefruit juice Fluoxetine
trazodone
Inhibition of CYP450 Serotonin syndrome
Grapefruit juice Simvastatin Inhibition of CYP450 Rhabdomyolysis, muscle weakness
Grapefruit juice Quinine Flavonoid naringen increases Quinine bioavailability Torsades de pointes
Grapefruit juice Warfarin Unknown GIT, pericardial haemorrhage

The pharmacological effect of a drug depends on its concentration at its site of action, which in turn depends on its rate of elimination. In many drugs, hepatic microsomal enzymes govern this. Inducers of the CYP450 hepatic microsomal system can result in rapid elimination and reduced bioavailability of certain drugs and may result in therapeutic failure, whereas opposite effects may be encountered when the same enzyme system is inhibited. Drug elimination is reduced and plasma half-life is increased manifold, which can lead to unwanted adverse effects.

Common herb-drug Interactions

Many herbs have the potential to induce the CYP450 enzyme system. Perhaps the most notable is St. John's Wort (Hypericum perforatum), which reduces the plasma concentration of many drugs such as amitriptyline, digoxin, theophylline, non-steroidal anti-inflammatories (NSAIDs), and oral contraceptive pills.13 St. John's Wort also increases the activity and expression of multidrug transporter P-glycoprotein efflux pumps in the duodenum. This mechanism has been implicated in its interactions with indinavir, digoxin, and cyclosporin. It also increases the metabolism of protease inhibitor indinavir, resulting in therapeutic failure. It has also been implicated for reducing cyclosporine bioavailability, an immunosuppressive agent given in transplant recipient patients.14,15

In conjunction with the use of medicinal herbs at the same time as warfarin, serious adverse effects have been encountered with warfarin due to herb-based inhibition of its metabolising enzymes. These include spontaneous postoperative bleeding, haematomas, haematemesis, melena, subarachnoid haemorrhage, subdural haematomas, and thrombosis. The herbs that can cause such adverse reactions include: Panax ginseng, Hypericum perforatum (St John's Wort), Gingko biloba, Serenoa repens, Angelica sinensis, Vaccinium species, Allium sativum (garlic), Zingiber officinale (ginger), Tanacetum parthenium, Lucium barbarum, Matricaria chamomilla, Boswellia serrate, and Camellia sinensis (tea).15 Zingiber officinale (ginger) is a common herbal medication that is used in motion sickness and inflammation. Ginkgo biloba is another common herbal remedy that is reputed to increase mental alertness. St John's Wort is an herbal remedy for treating depression. Vitamin K, a naturally occurring vitamin, is principally found in green leafy vegetables. It is suggested that Vitamin K intake from the diet should be restricted to 65–80 micrograms in patients who receive warfarin.15 Dietetic advice is recommended. Accordingly, physicians need to be aware of patients’ dietary habits, in addition to any unsupervised intake of herbal medications in order to prevent hazardous side effects.

The commonly used dietary supplement liquorice contains glycyrrhizin and glycyrrhetinic acid.16 These are potent inhibitors of 11-βhydroxy steroid dehydrogenase, causing raised cortisol and increased mineralocorticoid activity, leading to hypertension and suppression of the renin-angiotensin aldosterone system. Liquorice also interacts with various medicines such as some antihypertensives and some antiarrhythmics. Furanocoumarins found in grapefruit juice are potent inhibitors of the CYP enzyme system; bergamottin is the most potent of all. Furanocoumarins are found in many Chinese herbs. Flavonoids found in some herbal remedies also can cause significant inhibition of the CYP3A4 system. Similarly, people taking mono amine oxidase inhibitors (MAOIs) as prescription medications should avoid consuming Scotch broom (Cytisus scoparius) (which contains tyramine), as the combination may trigger a hypertensive crisis. Ginger, used by traditional Western and Chinese medicine to treat nausea, inactivates pro-emetic substances in the stomach. The same mechanism can hinder the absorption of certain drugs and neutralise their effect. Ginger can hinder the absorption of drugs by deactivating them in the stomach and therefore reducing their absorption.

Herbs of the genus Rehmannia have been shown to antagonise suppressant effect of steroids on the hypothalamic-pituitary-adrenal axis. In such cases, the physician needs to tailor the patients’ dose of steroids. Lower than usual therapeutic dose needs to be administered, otherwise adverse effects relating to increased steroid levels in the blood will increase. 17

Conclusion

As herbal supplement use becomes increasingly popular, issues regarding the safety of co-administration of these products together with conventional medicines need to be highlighted. Potential herb-drug interactions can be avoided by prescribing them in such a way that they do not result in any unwanted pharmacokinetic interaction, or by reducing the dose in case both the herb and the pharmaceutical drug have the same therapeutic action. (e.g., sedatives and hypoglycemic agents). Those who are elderly, debilitated, or receiving polypharmacy are more at risk for an herb-drug interaction and particular attention is required in these cases. For patients using CAM, it is essential for the physician to know more about the mechanism of action of drugs and herbs. An effective educational intervention could bridge this gap between acceptance and knowledge about CAM. Awareness programmes about the widespread usage of CAM should be organised for healthcare practitioners as well as medical students. Integration of herbal medicines into the curriculum of modern medicine programmes and continuing medical education, an interdisciplinary approach between the practitioners of herbal medicine and conventional medicine, and the availability of reputable pharmacopeias for reference are some of the ways to improve the situation.

ACKNOWLEDGEMENTS

None

Footnotes

PEER REVIEW

Commissioned. Peer reviewed.

CONFLICTS OF INTEREST

Raktim K Ghosh is an editorial board member of the Australasian Medical Journal.

Please cite this paper as: Bhadra R, Ravakhah K, Ghosh RK. Herb-drug interaction: The importance of communicating with primary care physicians. AMJ 2015;8(10): 315–319. http//dx.doi.org/10.4066/AMJ.2015.2479

References

  • 1.Rosenberg EI, Genao I, Chen I. et al. Complementary and alternative medicine use by primary care patients with chronic pain. Pain Med. 2008;9:1065–72. doi: 10.1111/j.1526-4637.2008.00477.x. [DOI] [PubMed] [Google Scholar]
  • 2.Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey: Household Component full-year files 2002 to 2008 [Internet] Rockville (MD) AHRQ; [cited 2015 Oct 15]. Available from: http://www.meps.ahrq.gov/mepsweb/data_stats/download_data_files.jsp. [Google Scholar]
  • 3.Roy V, Gupta M, Ghosh RK. Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India. Indian J Pharmacol. 2015;47:137–42. doi: 10.4103/0253-7613.153418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bjerså K, Stener Victorin E, Fagevik Olsén M. Knowledge about complementary, alternative and integrative medicine (CAM) among registered health care providers in Swedish surgical care: a national survey among university hospitals. BMC Complement Altern Med. 2012;12(42) doi: 10.1186/1472-6882-12-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tindle HA, Davis RB, Phillips RS. et al. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med. 2005;11:42–9. [PubMed] [Google Scholar]
  • 6.Wu CH, Wang CC, Tsai MT. et al. Trend and Pattern of Herb and Supplement Use in the United States: results from the 2002, 2007, and 2012 national health interview surveys. Evid Based Complement Alternat Med. 2014;2014 doi: 10.1155/2014/872320. 872320. doi: 10.1155/2014/872320. Epub 2014 Dec 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kennedy J. Herb and Supplement use in the US adult population. Clin Ther. 2005;27:1847–58. doi: 10.1016/j.clinthera.2005.11.004. [DOI] [PubMed] [Google Scholar]
  • 8.Lambert BL, Butin DN, Moran D. et al. Arthritis care: Comparison of physicians’ and patients’ views. Semin Arthritis Rheum. 2000;30:100–10. doi: 10.1053/sarh.2000.9203. [DOI] [PubMed] [Google Scholar]
  • 9.Zeilmann CA, Dole EJ, Skipper BJ. et al. Use of herbal medicine by elderly Hispanic and non-Hispanic white patients. Pharmacotherapy. 2003;23:526–32. doi: 10.1592/phco.23.4.526.32117. [DOI] [PubMed] [Google Scholar]
  • 10.Ventola CL. Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States: Part 1: The Widespread Use of CAM and the Need for Better-Informed Health Care Professionals to Provide Patient Counseling. Pharmacy and Therapeutics. 2010;35:461–8. [PMC free article] [PubMed] [Google Scholar]
  • 11.Kennedy J, Wang C-C, Wu C-H. et al. Patient Disclosure about Herb and Supplement Use among Adults in the US. Evid Based Complement Alternat Med. 2008 Dec;5:451–456. doi: 10.1093/ecam/nem045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bell IR, Caspi O, Schwartz GE. et al. Integrative medicine and systemic outcomes research: Issues in the emergence of a new model for primary health care. Arch Intern Med. 2002;162:133–40. doi: 10.1001/archinte.162.2.133. [DOI] [PubMed] [Google Scholar]
  • 13.Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61:2163–75. doi: 10.2165/00003495-200161150-00002. [DOI] [PubMed] [Google Scholar]
  • 14.Mai I, Kruger H, Budde K. et al. Hazardous pharmacokinetic interaction of Saint John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther. 2000;38:500–2. doi: 10.5414/cpp38500. [DOI] [PubMed] [Google Scholar]
  • 15.Milić N, Milosević N, Golocorbin Kon. et al. Warfarin interactions with medicinal herbs. Nat Prod Commun. 2014;9:1211–6. [PubMed] [Google Scholar]
  • 16.Serra A, Uehlinger DE, Ferrari P. et al. Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol. 2002;13:191–6. doi: 10.1681/ASN.V131191. [DOI] [PubMed] [Google Scholar]
  • 17.Zha LL. Experimental effect of Rehmannia glutinosa on the pituitary and adrenal cortex in a glucocorticoid inhibition model using rabbits. Zhong Xi Yi Jie He Za Zhi. 1999 Feb;8(2):95–7. 70. [PubMed] [Google Scholar]
  • 18.Johne A, Brockmöller J, Bauer S. et al. Pharmacokinetic interaction of digoxin with an herbal extract from St Johnís wort (Hypericum perforatum). Clin Pharmacol Ther. 1999;66:338–45. doi: 10.1053/cp.1999.v66.a101944. [DOI] [PubMed] [Google Scholar]
  • 19.Lau WC, Carville DG, Guyer KE. et al. St. Johnís wort enhances the platelet inhibitory effect of clopidogrel in clopidogrel resistant healthy volunteers. J Am Coll Cardiol. 2005;45:382A. [Google Scholar]
  • 20.Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 1996;46:1775–6. doi: 10.1212/wnl.46.6.1775. [DOI] [PubMed] [Google Scholar]
  • 21.Srivastava KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Med Hypothesis. 1989;29:25–8. doi: 10.1016/0306-9877(89)90162-x. [DOI] [PubMed] [Google Scholar]
  • 22.Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm. 1997;54:692–3. doi: 10.1093/ajhp/54.6.692. [DOI] [PubMed] [Google Scholar]
  • 23.Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology. 2004;62:670. doi: 10.1212/wnl.62.4.670. [DOI] [PubMed] [Google Scholar]
  • 24.Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ. 2003;327:1454. doi: 10.1136/bmj.327.7429.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lurie Y, Loebstein R, Kurnik D. et al. Warfarin and vitamin K intake in the era of pharmacogenetics. Br J of Clin Pharmacol. 2010;70:164–70. doi: 10.1111/j.1365-2125.2010.03672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Australasian Medical Journal are provided here courtesy of Australasian Medical Journal

RESOURCES